BioCryst Pharmaceuticals Inc (BCRX)
Healthcare
Drug Manufacturers - Specialty & Generic
9.00 $
-2.8%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns BioCryst Pharmaceuticals Inc (BCRX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 87.0% of the shares are freely tradable; institutional investors hold 101.1%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
101.1%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
1.2%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
87.0%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
12.4%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
254Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 8.91 | 22,650,988 | -3.2 | 03/31/2026 |
| RA Capital Management, LLC | 6.23 | 15,827,186 | +0.0 | 03/31/2026 |
| Deerfield Management Co | 5.92 | 15,038,000 | +4.9 | 03/31/2026 |
| State Street Corp | 4.80 | 12,208,360 | +5.2 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 4.42 | 11,244,625 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.38 | 11,135,762 | +0.0 | 03/31/2026 |
| TCG Crossover Management, LLC | 4.34 | 11,020,968 | +0.0 | 03/31/2026 |
| HHG PLC | 3.51 | 8,908,506 | +20.3 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| State Street® SPDR® S&P® Biotech ETF | 3.69 | 9,386,021 | -1.0 | 07/30/2026 |
| Vanguard Morn Total Stk Mkt Idx Investor | 3.18 | 8,070,274 | +0.1 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.